CALIVIDA contains levocetirizine dihydrochloride, a new-generation anti-histamine, is available in
the following dosage forms:
0.5mg/ml strawberry flavored oral solution in a 200ml bottle
5mg film-coated tablets, packs of 28
CALIVIDA is indicated for the treatment of seasonal, perennial and persisting allergic rhinitis (hay
fever and pollinosis), allergic conjunctivitis and chronic idiopathic urticaria.